Trampy-You are correct, my mistake. They are in the process of considering it for C-I, but have not gotten there yet. Regardless, the point remains the same. DEA will only go after those persons who are receiving, selling, or using target drugs. Rohypnol is definitely a target drug (see below). I feel honored that you used three paragraphs to point out this mistake. Boy does it ever suck to be a human. I guess this means I am capable of error.

http://www.usdoj.gov/dea/pubs/rohypnol/rohypnol.htm

Patient2all- I agree the original post needs answering, but no one on this board can answer a vague question such as the original post. We can try to give general outlines such as we’ve already done. Without details we are guessing. The original post said only that they had received prior shipments from a no prescription site. If any of the meds were scheduled, then there are several scenarios;

1) The shipment came from an IOP. US Customs (ICE) would have jurisdiction then, but they won’t touch it unless it is a large amount or a C-I.
2) The shipment came from inside the U.S. and DEA has jurisdiction. Again, the issue is quantity or type.
3) The local narcotics taskforce caught on and they have an axe to grind. The local taskforces usually won’t touch anything that is obtained from a doctor, unless there is fraud involved.
4) The delivery driver made a mistake and delivered it. The rest of this is a combination of guilty conscience and paranoid neighbor.

More information is needed to make this person feel better about potentially breaking the law. Guilt is supposed to be part of doing something you know, or think, may be wrong. I am done with this post.